Evidence for translation of rabbit globin mRNA after liposomemediated insertion into a human cell line

No abstract is available for this paper.

• Publication year

  1978

• Venue

  Nature

• Publication date

  1978-08-31

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/274921A0PMID 683335
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MRNA-directed synthesis of catalytically active mouse beta-glucuronidase in Xenopus oocytes.

  1977cited by this paper
• Competition between globin messenger ribonucleic acids for a discriminating initiation factor.

  1977cited by this paper
• Incorporation of high molecular weight RNA into large artificial lipid vesicles.

  1977cited by this paper
• Induction and decay of human fibroblast interferon mRNA.

  1977cited by this paper
• Regulatory function of simian virus 40 DNA replication for late viral gene expression.

  1977cited by this paper
• Rapid partial purification of placental glucocerebroside beta-glucosidase and its entrapment in liposomes.

  1977cited by this paper
• BBA reportLarge volume liposomes by an ether vaporization method

  1976cited by this paper
• Large volume liposomes by an ether vaporization method.

  1976cited by this paper
• A comparison of negatively and positively charged liposomes containing entrapped polyinosinic-polycytidylic acid for interferon induction in mice.

  1976cited by this paper
• Translation of ovalbumin mRNA in Xenopus laevis oocytes. Characterization of the system and effects of estrogen on injected mRNA populations.

  1976cited by this paper
• The use of a liposomally entrapped enzyme in the treatment of an artificial storage condition.

  1976cited by this paper
• Introduction of purified hexosaminidase A into Tay-Sachs leukocytes by means of immunoglobulin-coated liposomes.

  1976cited by this paper
• Immune RNA in neoplasia

  1976cited by this paper
• Microinjection studies of duck globin messenger RNA translation in human and avian cells.

  1976cited by this paper
• In vitro conversion of normal mouse lymphocytes by plasmacytoma RNA to express idiotypic specificities on their surface characteristic of the plasmacytoma immunoglobulin.

  1974cited by this paper
• Different size of the product of the 14S light chain mRNA translated in vitro and in amphibian oocytes

  1973cited by this paper
• Physical and chemical characterization of RNA incorporated by rabbit spleen cells.

  1973cited by this paper
• Interferon messenger RNA: translation in heterologous cells.

  1972cited by this paper
• Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose.

  1972cited by this paper
• Rabbit haemoglobin synthesis in frog cells: the translation of reticulocyte 9 s RNA in frog oocytes.

  1971cited by this paper
• The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

  1969cited by this paper
• The use of affinity chromatography for the specific purification of antibodies and antigens.

  1969cited by this paper
• Hemoglobin messenger ribonucleic acid. Synthesis of 9S and ribosomal ribonucleic acid during erythroid cell development.

  1969cited by this paper
• Antibody formation initiated in vitro. 3. Antibody formation and allotypic specificity directed by ribonucleic acid from peritoneal exudate cells.

  1966cited by this paper

• mRNA technology for the prevention and treatment of HIV-1 infection

  2026cites this paper
• Design principles of lipid nanoparticles for RNA delivery

  2026cites this paper
• The mRNA-Based Innovative Strategy: Progress and Challenges

  2026cites this paper
• Engineering Lipid Nanoparticles for mRNA Immunotherapy

  2025cites this paper
• More than a delivery system: the evolving role of lipid-based nanoparticles.

  2025cites this paper
• Macrophage-targeted Mms6 mRNA-lipid nanoparticles promote locomotor functional recovery after traumatic spinal cord injury in mice

  2025cites this paper
• Transfection via RNA-Based Nanoparticles: Comparing Encapsulation vs Adsorption Approaches of RNA Incorporation.

  2025cites this paper
• Overview on LNP-mRNA encapsulation unit operation: Mixing technologies, scalability, and influence of formulation & process parameters on physico-chemical characteristics.

  2025cites this paper
• Computational Methods for Modeling Lipid-Mediated Active Pharmaceutical Ingredient Delivery

  2025cites this paper
• Nano/micro-scale targeted RNA delivery systems for cancer therapy.

  2025cites this paper
• Impact of cell line and reporter gene selection on in-vitro transfection evaluation of mRNA lipid nanoparticles

  2025cites this paper
• Lipid nanoparticle-assisted mRNA therapy for cancer treatment

  2025cites this paper
• Stimuli-Responsive Nanomaterials for the Precision Delivery of mRNA Cancer Vaccines

  2025cites this paper
• Unraveling the potential: mRNA therapeutics in oncology

  2025cites this paper
• Harnessing mRNA technology for ischemic heart disease: a review of regenerative and protective therapies

  2025cites this paper
• Rational design of lipid nanoparticles for enabling gene therapies

  2025cites this paper
• Lipid Nanoparticle Development for A Fluvid mRNA Vaccine Targeting Seasonal Influenza and SARS-CoV-2

  2025cites this paper
• The mRNA vaccine contributors: Assessing their impact through a mainstream lens

  2025cites this paper
• Nucleic Acid Nanocapsules as a New Platform to Deliver Therapeutic Nucleic Acids for Gene Regulation.

  2025cites this paper
• Comparative Analysis of RNAs’ Delivery Systems in diabetic wound healing: Mechanisms, Applications, and Future Prospects

  2025cites this paper
• Unlock the sustained therapeutic efficacy of mRNA.

  2025cites this paper
• Exosome theranostics: Comparative analysis of P body and exosome proteins and their mutations for clinical applications

  2024cites this paper
• Advances in the development of lipid nanoparticles for ophthalmic therapeutics.

  2024cites this paper
• Delivery of nucleic acid drugs for tumor therapy: Opportunities and challenges

  2024cites this paper
• RNA therapeutics: Molecular mechanisms, and potential clinical translations.

  2024cites this paper
• Lipid nanoparticles for RNA delivery: Self-assembling vs driven-assembling strategies.

  2024cites this paper
• Review: N1-methyl-pseudouridine (m1Ψ): Friend or foe of cancer?

  2024cites this paper
• Unlocking the potential of nanocarrier-mediated mRNA delivery across diverse biomedical frontiers: A comprehensive review.

  2024cites this paper
• Lipid-nanoparticle-enabled nucleic acid therapeutics for liver disorders

  2024cites this paper
• Analysis of Macromolecular Systems as Enabler for Energy and Life Science Applications

  2024cites this paper
• Strategies for Organ-Targeted mRNA Delivery by Lipid Nanoparticles.

  2024cites this paper
• Pharmaceutical strategies for optimized mRNA expression.

  2024cites this paper
• Advances and prospects of RNA delivery nanoplatforms for cancer therapy

  2024cites this paper
• Current landscape of mRNA technologies and delivery systems for new modality therapeutics

  2024cites this paper
• The 60-year evolution of lipid nanoparticles for nucleic acid delivery

  2024cites this paper
• Enhancing RNA-lipid nanoparticle delivery: Organ- and cell-specificity and barcoding strategies

  2024cites this paper
• Advances in the design and delivery of RNA vaccines for infectious diseases.

  2024cites this paper
• Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19?

  2023cites this paper
• Nonreplicating synthetic mRNA vaccines: A journey through the European (Journal of Immunology) history

  2023cites this paper
• Zwitterionic materials for nucleic acid delivery and therapeutic applications.

  2023cites this paper
• Nobel Prize for physiology or medicine in 2023: how to dupe the cellular innate immune system using modified RNA for therapeutic treatment

  2023cites this paper
• Emerging delivery approaches for targeted pulmonary fibrosis treatment.

  2023cites this paper
• Considerations on the design of lipid-based mRNA vaccines against cancer.

  2023cites this paper
• mRNA and Synthesis-Based Therapeutic Proteins: A Non-Recombinant Affordable Option

  2023cites this paper
• An insight of different classes of RNA-based therapeutic, nanodelivery and clinical status: current landscape

  2023cites this paper
• Malaria & mRNA Vaccines: A Possible Salvation from One of the Most Relevant Infectious Diseases of the Global South

  2023cites this paper
• From De Novo Design to Redesign: Harnessing Computational Protein Design for Understanding SARS-CoV-2 Molecular Mechanisms and Developing Therapeutics.

  2023cites this paper
• Engineered mRNA Delivery Systems for Biomedical Applications

  2023cites this paper
• The impact of BNT162b2 mRNA vaccine on adaptive and innate immune responses.

  2023cites this paper
• Microfluidic synthesis of nanomaterials for biomedical applications.

  2023cites this paper
• Nanoadjuvants: Promising Bioinspired and Biomimetic Approaches in Vaccine Innovation

  2023cites this paper
• Progress in vaccine development for infectious diseases—a Keystone Symposia report

  2023cites this paper
• mRNA-based cancer therapeutics

  2023cites this paper
• Public Interest in Myocarditis during the SARS-CoV-2 Pandemic

  2023cites this paper
• Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging

  2022cites this paper
• The Potential of Nanomedicine to Unlock the Limitless Applications of mRNA

  2022cites this paper
• Nonviral Delivery Systems of mRNA Vaccines for Cancer Gene Therapy

  2022cites this paper
• Advances in COVID-19 mRNA vaccine development

  2022cites this paper
• Application of lipid-based nanoparticles in cancer immunotherapy

  2022cites this paper
• mRNA vaccines in the prevention and treatment of diseases

  2022cites this paper
• Oligonucleotide separation techniques for purification and analysis: What can we learn for today's tasks?

  2022cites this paper
• The landscape of mRNA nanomedicine

  2022cites this paper
• Antitumor Activity of Anti‐miR‐21 Delivered through Lipid Nanoparticles

  2022cites this paper
• Evolution of complexity in non-viral oligonucleotide delivery systems: from gymnotic delivery through bioconjugates to biomimetic nanoparticles

  2022cites this paper
• mRNA therapy for myocardial infarction: A review of targets and delivery vehicles

  2022cites this paper
• A tale of nucleic acid–ionizable lipid nanoparticles: Design and manufacturing technology and advancement

  2022cites this paper
• Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics

  2022cites this paper
• Quality by Design Approach in Liposomal Formulations: Robust Product Development

  2022cites this paper
• COVID-19 mRNA vaccines: Platforms and current developments

  2022cites this paper
• The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines

  2021cites this paper
• Lipid nanoparticles for mRNA delivery

  2021cites this paper
• The tangled history of mRNA vaccines

  2021cites this paper
• The nano delivery systems and applications of mRNA

  2021cites this paper
• Calcium-mediated binding of DNA to 1,2-distearoyl-sn-glycero-3-phosphocholine-containing mixed lipid monolayers.

  2014cites this paper
• Functional Magnetic Nanoparticles for Non-Viral Gene Delivery and MR Imaging

  2013cites this paper
• Triazine Dendrimers for DNA and siRNA Delivery: Progress, Challenges, and Opportunities

  2012cites this paper
• Neutral Liposomes and DNA Transfection

  2011cites this paper
• Nonviral vectors for gene delivery.

  2009cites this paper
• Liposomes as vehicles for cellular incorporation of biologically active macromolecules

  2007cites this paper
• Liposome-protoplast interactions

  2007cites this paper
• Liposome-Mediated transfer of bacterial RNA into carrot protoplasts

  2004cites this paper
• Lipídios catiônicos anfifílicos, como neutralizadores da carga elétrica do DNA para transfecção in vitro de células eucarióticas.

  2002cites this paper
• Comparative study of the protection of modified and unmodified dsDNA by cationic and non-cationic lipids and liposomes to digestion by DNase I

  1998cites this paper
• Induction of virus‐specific cytotoxic T lymphocytes in vivo by liposome‐entrapped mRNA

  1993cites this paper
• Concepts on the use of liposomal antimicrobial agents: applications for aminoglycosides.

  1992cites this paper
• Interaction of membrane phospholipids with some DNA substructures studied by means of differential scanning calorimetry.

  1992cites this paper
• Quantitation of alveolar distribution of liposome-entrapped antioxidant enzymes.

  1992cites this paper
• Maintenance of liver function in long term culture of hepatocytes following In Vitro or In Vivo Ha-rasEJ transfection

  1991cites this paper
• Generating and loading of liposomal systems for drug-delivery applications

  1989cites this paper
• [9] Liposome preparation and size characterization

  1989cites this paper
• Use of liposomes as injectable-drug delivery systems.

  1989cites this paper
• Differential behavior of liposome-introduced specific RNAs in living Drosophila cells.

  1988cites this paper
• Expression of mRNA electroporated into plant and animal cells.

  1987cites this paper
• Techniques for encapsulating bioactive agents into liposomes.

  1986cites this paper
• Recovery of normal protein synthesis in heat-shocked chicken myotubes by liposome-mediated transfer of mRNAs.

  1985cites this paper
• [Use of liposomes as carriers in the transport of substances of biological value to cells].

  1984cites this paper
• Microinjection of somatic cells with micropipettes: comparison with other transfer techniques.

  1984cites this paper
• Liposome-mediated insertion of intact DNA into isolated nuclei. Potential for a new in vitro transcription system.

  1983cites this paper
• The theory and practical applications of liposome-protoplast interactions.

  1983cites this paper
• Targeting to lymphoid cells of the immune network.

  1983cites this paper